Drexel University - Comprehensive, integrated academics enhanced by co-operative education, technology, and research opportunities. | Drexel University
Drexel University
Search events. View events.

All Categories

Click for help in using calendar displays. Print the contents of the current screen.
Display Format: 
Event Details
Notify me if this event changes.Add this event to my personal calendar.
Go Back
Democratizing Cell Therapies
Start Date: 3/30/2022Start Time: 4:00 PM
End Date: 3/30/2022End Time: 5:30 PM

Event Description
BIOMED Seminar


Democratizing Cell Therapies

Jill Carton, PhD
Senior Director
CAR Engineering and Protein Sciences
Century Therapeutic

Century Therapeutics is developing genetically engineered, inducible pluripotent stem cell or IPSC-derived iNK and iT cell product candidates for hematologic and solid tumor malignancies that have the potential to overcome the limitations of first-generation cell therapies. Autologous chimeric antigen receptor T cells (CAR-Ts) have shown proof of concept and valuable clinical efficacy, but face several inherent limitations, including the dysfunction of the patients own T-cells, patient-to-patient variability resulting in variable efficacy and toxicities, and a limited number of tolerated genetic manipulations, which limit their therapeutic potential.

Century Therapeutics is leveraging its iPSC platform to develop allogeneic cell therapies that go beyond what is achievable by autologous products and donor derived allogeneic cell therapies. The presentation will review the core technologies and science behind our platform and the exciting novel therapeutics we are advancing.

Jill Carton, PhD, is a Senior Director of CAR Engineering and Protein Sciences at Century Therapeutic in Philadelphia, PA. Jill and her team discover tumor antigen binders and engineer the therapeutic chimeric antigen receptors (CARs) that are incorporated into Century Therapeutics allogeneic cell therapies.

Prior to joining Century Therapeutics in 2019, Jill worked at Janssen Pharmaceuticals in the Biologics Research Department for over 20 years. During that time, she progressed more than 8 biologics drugs through the discovery department and into the clinic. Three of the drugs are currently marketed biologics. Jill received her MS and PhD degrees from Fordham University, Bronx NY, and her BS from Fairfield University, in Fairfield, CT.
Contact Information:
Name: Lisa Williams
Email: ltw22@drexel.edu
Jill Carton
Remote Webinar
  • Everyone

  • Display Month:

    Advanced Search (New Search)
    Date Range:
    Time Range:

    Special Features: 

    Select item(s) to Search

    Select item(s) to Search
    Select item(s) to Search
    Select item(s) to Search